← Eichor
Study identifier: NCT06376097 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.

Condition: Lung Cancer  ·  Sponsor: AstraZeneca

PhaseN/A
Planned participants1000
Who can joinAll sexes, 45 Years to 74 Years
Healthy volunteersNo

About this study

Observational study that aims to evaluate the implementation of a lung cancer screening program in a smoker population included in a public heath service.

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center  ·  1-877-240-9479  ·  information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital das Clínicas da Faculdade de Medicina de Botucatu (HCFMB)Botucatu, São Paulo, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06376097